Combination therapies using Poly(I:C), OX40 agonist and TIM-3 inhibitor with and without the addition of allogeneic Neuro2a/GM-CSF-secreting cells induced complete tumor regression in 90% of mice that led to improved survival and tumor-specific immunological memory. The gene discussed is HAVCR2; the disease is neoplasm.